Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Susi Subay"'
Autor:
Soedarsono Soedarsono, Ni Made Mertaniasih, Tutik Kusmiati, Ariani Permatasari, Susi Subay, Suko Hari Adiono
Publikováno v:
International Journal of Mycobacteriology, Vol 13, Iss 2, Pp 140-146 (2024)
Background: Bedaquiline is one of the core drugs used to treat multidrug-resistant TB (MDR-TB). Delamanid is one of the companion drugs in group C which is used to complete the treatment regimen when drugs in groups A and B can not be used. This stud
Externí odkaz:
https://doaj.org/article/e3ebac929b1342199b6e6390cca0eaa3
Publikováno v:
Perspectives in Clinical Research, Vol 15, Iss 2, Pp 89-93 (2024)
Background: Bedaquiline and delamanid have been included in the individualized treatment regimen (ITR) to treat patients with drug-resistant tuberculosis (DR-TB). Objective: The objective of this study is to compare the effectiveness of sputum cultur
Externí odkaz:
https://doaj.org/article/57c8d30027d64e088344e7b7f14821cd
Publikováno v:
International Journal of Mycobacteriology, Vol 12, Iss 3, Pp 241-247 (2023)
Background: Bedaquiline is a core drug with an optimized background regimen for treating drug-resistant tuberculosis (DR-TB) patients. One of the adverse effects of bedaquiline is QT-corrected (QTc) interval prolongation. TB patients with diabetes me
Externí odkaz:
https://doaj.org/article/e7340dc588d846c4880d24ef4f8685bd
Publikováno v:
Asian Pacific Journal of Tropical Medicine, Vol 16, Iss 4, Pp 169-175 (2023)
Objective: To evaluate early efficacy of sputum conversion within 6 months of individual regimens containing bedaquiline in patients with drug resistant tuberculosis. Methods: We conducted a retrospective study among patients with drug resistant tube
Externí odkaz:
https://doaj.org/article/d719136e2d454b369ba9a9fbfc26d454
Publikováno v:
International Journal of Mycobacteriology, Vol 12, Iss 1, Pp 1-9 (2023)
Background: Drug-resistant tuberculosis (DR-TB) is a public health concern that is difficult to treat, requiring long and complex treatment with highly effective drugs. Bedaquiline and/or delamanid have already shown promising outcomes in patients wi
Externí odkaz:
https://doaj.org/article/6e0e7954606f49659c4a606219fe560b
Publikováno v:
Asian Pacific Journal of Tropical Medicine. 16:169
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37a3951b2dd10f992499001b9b576799
https://doi.org/10.4103/1995-7645.372289
https://doi.org/10.4103/1995-7645.372289
Publikováno v:
International Journal of Mycobacteriology. 12:1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b1df52a6de7feb959b1857ea2b9075a
https://doi.org/10.4103/ijmy.ijmy_217_22
https://doi.org/10.4103/ijmy.ijmy_217_22